# Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention

> **NCT01455935** · PHASE2 · UNKNOWN · sponsor: **Jacobs Neurological Institute** · enrollment: 90 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Anti-platelets and statin
- **DRUG:** alteplase
- **PROCEDURE:** intra arterial intervention

## Key facts

- **NCT ID:** NCT01455935
- **Lead sponsor:** Jacobs Neurological Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2013-12
- **Final completion:** 2014-02
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2012-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455935, "Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01455935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*